Cargando…
T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis
BACKGROUND: Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of childhood mortality worldwide. Two types of pertussis vaccines are currently available, whole-cell, and the more recent acellular vaccines. Because of reduced reactogenicity and comparable...
Autores principales: | Feunou Feunou, Pascal, Bertout, Julie, Locht, Camille |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855369/ https://www.ncbi.nlm.nih.gov/pubmed/20419113 http://dx.doi.org/10.1371/journal.pone.0010178 |
Ejemplares similares
-
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017) -
Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping Cough
por: Mielcarek, Nathalie, et al.
Publicado: (2006) -
Attenuated recombinant Bordetella pertussis as live vaccines for the protection against homologous and heterologous diseases
por: Locht, C., et al.
Publicado: (1997) -
Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases
por: Cauchi, Stéphane, et al.
Publicado: (2018) -
Live attenuated pertussis vaccine for prevention and treatment of allergic airway inflammation in mice
por: Belcher, Thomas, et al.
Publicado: (2022)